Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
about
Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects.Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.The management of HIV-1 protease inhibitor pharmacokinetic interactions.Acid suppressive therapy and the effects on protease inhibitors.Drug interactions between proton pump inhibitors and antiretroviral drugs.Fosamprenavir calcium plus ritonavir for HIV infection.Interactions between protease inhibitors and acid-reducing agents: a systematic review.A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteersEffect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.Clinically significant drug interactions with antacids: an update.The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapy.Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
P2860
Q33155841-EF6FC311-2236-4BFA-80B0-87FCCFC409ABQ35647752-A423E21B-F608-4466-9880-0662E7A38463Q36154861-375BF548-46B9-400E-B116-CB7018548AF0Q36640626-5BD02717-7510-4DD8-89D0-2B8762DA4A07Q36788409-7848CF8B-C4DA-4023-A3EE-D0895665CAD0Q36839698-AFA72739-E362-4EE6-BF8B-69DE88F6F448Q36895942-4637717B-A1BC-42B1-8A9A-F64B7D0F7659Q36922216-F24A15A0-FDDE-42EA-976F-19FA412D13BBQ37352380-BD71B11C-BE6E-4440-9D1C-76A93B32DDE6Q37378110-CE3FAA27-F4A4-4309-88E4-E915B5B5F0CCQ37937722-2ED2E792-FE03-4A18-A596-BD0A9CAF10B3Q43165983-71A408F4-E35B-48FA-BD2A-BD974015830CQ46623386-92D867F9-9A2A-4B3E-8E0F-F0311187258E
P2860
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@ast
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@en
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@nl
type
label
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@ast
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@en
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@nl
prefLabel
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@ast
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@en
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@nl
P2093
P2860
P1476
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
@en
P2093
Daniel S Stein
Katherine L Baker
Mary B Wire
Susan L Ford
P2860
P304
P356
10.1128/AAC.49.1.467-469.2005
P407
P577
2005-01-01T00:00:00Z